Neurologic clinical trial - CSL Behring

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05568888

A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra® / Beriplex®]) to Improve Survival in Patients with Traumatic Injury and Confirmed or Suspected Acute Major Bleeding Predicted to Receive a Large Volume Blood Product Transfusion

Drug

BE1116

Phase

Phase III

Keywords

Traumatic injury